← Leaderboards
David Beasely
University Of Texas Med Br Galveston
$3,068,505
Attributed
$3,068,505
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2019–21$2M$1.5M$1M$500K$0
'19
'20
'21
Funding mix
By agency
NIH$3,068,505 · 1
By mechanism
N01$3,068,505 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Alexander Bukreyev$20,278,136
- David Beasley$17,578,609
- Trevor Brasel$2,096,208
- Melissa Eitzen$1,533,720
- James W. Leduc$66,178,028
Others in their field
Other Emerging Leaders on “Infectious Disease Model”
- Ted Ross · University Of Georgia$71,962,304
- Prasant Mohapatra · University Of California At Davis$54,605,575
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr$18,698,011
- David Beasley · University Of Texas Med Br Galveston$16,507,955
- Greg Westergaard · Alpha Genesis Inc$15,750,123
Research focus
Infectious Disease ModelContractsLicensureEfficacy TestingAnimal ModelAnimal Model DevelopmentStandardizationOryctolagus CuniculusRodent ModelTherapeutic EvaluationAnthrax DiseaseBacillus AnthracisEvaluationFilovirusInhalationMedical CountermeasureAntimicrobial Resistance
Grant awards (4)
Task A29: Evaluation of Candidate Medical Countermeasures for Inhalational Anthrax in the NZW Rabbit Model$1,204,421
N01 · FY2021 · AI · contact PI
Task A35: Rodent models for testing therapeutics against Filoviruses$177,222
N01 · FY2021 · AI · contact PI
Task A35: Rodent models for testing therapeutics against Filoviruses$507,188
N01 · FY2020 · AI · contact PI
Task A29: Evaluation of Candidate Medical Countermeasures for Inhalational Anthrax in the NZW Rabbit Model$1,179,674
N01 · FY2019 · AI · contact PI